Dave Fornell, DAIC Editor

Dave Fornell, editor of DAIC Magazine

Blog | Dave Fornell, DAIC Editor | Coronavirus (COVID-19)| January 04, 2021

COVID Vaccines May Make the Future Brighter in 2021, if They Ever Arrive

The U.S. Government promised to have 20 million people vaccinated by Jan. 1, 2021 with just the Pfizer Vaccine. Even with two vaccines now approved, U.S. vaccinations for COVID stand at less than 4.5 million on Jan. 4, 2020. Getty Images The Pfizer and Moderna COVID vaccines were hailed as a major accomplishment in modern science and as the beginning of the end for COVID. This very well may be true, but it absolutely will not happen as fast as the government has led us to believe. #COVID19 #COVID #SARScov2

The U.S. Government promised to have 20 million healthcare workers and nursing home residents vaccinated by Jan. 1, 2021 with just the Pfizer vaccine. Even with two vaccines now approved, U.S. vaccinations for COVID stand at less than 4.5 million on Jan. 4, 2020. Getty Images

There was much fanfare over the U.S. Food and Drug Administration (FDA) emergency use authorizations (EUAs) in December for the Pfizer and Moderna COVID-19 (SARS-CoV-2) vaccines. However, the vaccination program to date has fallen very far short the promises made by the government when the first vaccine was approved, with less than one quarter of the promised vaccine being delivered.

The vaccines were hailed as a major accomplishment in modern science and as the beginning of the end for COVID. This very well may be true, but it absolutely will not happen as fast as the government has led us to believe. 

The Pfizer vaccine was approved Dec. 14, and the Centers for Disease Control (CDC) and federal officials said the plan was to get the first doses to 20 million Americans by Jan. 1, 2021. The second Moderna vaccine, approved Dec. 18, was supposed to add millions of additional doses by the end of 2020 as well. As of today, Jan. 4, only about 4.5 million have actually been vaccinated, far below what was promised.

And this report comes as Pfizer reports it still has millions of doses awaiting shipment in its warehouse that the federal government has not yet picked up. The drug maker says delays in getting the shipments out to hospitals is due to the federal government's logistical issues, not an issue with production and supply. If this is the case, the federal government should have done more to prepare for the vaccine with procuring adequate transportation and deep-freezer capacity. It appears the government was caught off guard and unprepared, but knew for months what was required for the handling of these fragile messenger RNA (mRNA) vaccines that need to be stored at minus 80 degrees below zero.

However, this preparedness has been handicapped by President Trump's poor leadership, because he believes the Democrats are more of a threat to the nation than the virus. The federal leadership for preparedness and response to contain and confront the virus has been severely lacking, uncoordinated, not based on science and made into a political debate rather than a scientific discussion. Doctors, scientific leaders and agencies like the CDC who could take the lead have largely been muzzled due to Trump's poor leadership.

After tuning out the news for the week of New Years, I found today, Jan. 4,  the news is filled with stories on why the roll out has been so slow. Most sources place blame on federal officials for not getting out the doses as fast as they originally promised weeks ago. States are saying they are dispensing all the doses they have received and are waiting for additional, promised shipments that have been delayed from the federal level. 

Most states and hospitals are reporting much smaller shipments of doses than originally anticipated. Since the supply appears to be limited and quantities being shipped are not guaranteed, many healthcare systems are holding back 50 percent of the doses they have already received. This is to ensure they have enough supply to deliver the second vaccination 18-21 days after the first injection for all those who already received their first dose. 

At this point, only healthcare workers, nursing home workers and nursing home residents are eligible in Phase 1a of the CDC plan to roll out the vaccines. The CDC estimated there are 21 million U.S. healthcare personnel and 3 million nursing home residents that are first in line to receive the vaccines. At the current rate of vaccination, it will take until late March to vaccinate everyone in the Phase 1a group before moving on to other essential workers. It is estimated at least 40-60 million others fall into the Phase 1b and 1c groups that are next in line before the general population will be able to receive the vaccine. At the current rate of vaccination, the general public would not be able to get vaccinated until August or September. 

Read more on Who Qualifies for the COVID Vaccine Under CDC Guidelines

I am happy to report my wife, a pharmacist with Northwestern Medicine in the Chicago area, was able to get the vaccine as an early Christmas present Dec. 21. However, for average people like myself, I do not expect to be able to get the vaccine much before mid to late summer 2021, based on what I am seeing with the the current roll out. This means that "normal" life will not return until maybe mid-fall of 2021 at the earliest, unless the U.S. government steps up its game on vaccine distribution and the virus is depoliticized.

The vaccine also takes on a new urgency in some regions that are in the middle of a massive wave of COVID hospitalizations and are about to be overwhelmed. This includes at least one county in southern California reporting 0 to 1.5 percent open ICU bed capacity. 

Since early December, COVID deaths have averaged between 2,000-3,000 deaths per day. This is equal to losing as many people as we did on Sept. 11, 2001, every day for a month straight. The U.S. just crossed 350,000 dead from the pandemic, which for comparison, far outnumbers all the U.S. military casualties from all conflicts since WWII combined. 

In this sense, we are at war with the virus, and so far it is doing a much better job of killing Americans than the diligent efforts of all of our enemies combined from the past 75 years. Hopefully in 2021, this country begins to treat the fight against COVID more as a war effort and not as just an inconvenience to their lives, or shrug it off as a low-grade sickness that is not any worse than the flu. 

Wishing everyone a healthy new year.  

I am interested to hear how the vaccine roll out is going at your hospitals and I am collecting images of clinicians getting their vaccine. Feel free to e-mail me at [email protected]
 

Find more COVID-19 related content

Related Content

#breakingnews The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. It is the first vaccine to be fully approved by the FDA, and experts say it is expected to open the door for further vaccine mandates.

Getty Images

News | Coronavirus (COVID-19) | August 23, 2021
August 23, 2021 — The U.S.
The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compromised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images #AHA #coronavirus #COVID19

The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compormised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images

News | Coronavirus (COVID-19) | August 18, 2021 | By Dave Fornell, Editor
August 18, 2021 — The U.S.
In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. ACC, HRS, ASNC, SCMR, SCCT, ASE, HFSA, STS, SCAI.

In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. 

Feature | Coronavirus (COVID-19) | July 30, 2021 | By Dave Fornell, Editor
July 30, 2021 — A coalition of 10 U.S.-based cardiovascular societies have issued a statement today in support of all
AHA president says COVID has a direct impact on the heart and preventive measures for heart disease largely went out the window during the pandemic

Getty Images

News | Coronavirus (COVID-19) | July 26, 2021
July 26, 2021 — Heart disease and stroke continue to kill more people in the U.S.
A new study with data from more than 10,000 COVID patients confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19.

A new study with data from more than 10,000 COVID patients confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19. Researchers believe statins, which attach to the ACE2 receptors, may block the virus from attaching to these same receptors. 

News | Coronavirus (COVID-19) | July 21, 2021
July 21, 2021 — In a new study from University of California San Diego School of Medicine, researchers have confirmed
New trial results from the international RAPID Trial show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. How to anticoagulate COVID patients. How to prevent thrombus in COVID patients.

New trial results from the international RAPID Trial show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. Getty Images
 

Feature | Coronavirus (COVID-19) | July 15, 2021
July 15, 2021 — COVID-19 is m
Diluting of a blood sample for real-time deformability cytometry testing. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen. Germany, were able to show for the first time COVID-19 significantly changes the size and stiffness of red and white blood cells, sometimes over months. From the study How a COVID-19 Infection Changes Blood Cells in the Long Run. Reasons for long COVID.

Diluting of a blood sample for real-time deformability cytometry testing. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen. Germany, were able to show for the first time COVID-19 significantly changes the size and stiffness of red and white blood cells, sometimes over months.

News | Coronavirus (COVID-19) | July 15, 2021
July 15, 2021 — Using real-time deformability cytometry, researchers at the...
Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.

Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.

News | Coronavirus (COVID-19) | June 28, 2021
June 28, 2021 - A recent analysis found that children and adolescents with multisystem inflammatory syndrome in child
The U.S. Food and Drug Administration (FDA) announced June 25 it has added a warning on the Moderna and Pfizer COVID-19 messenger RNA (mRNA) vaccine fact sheets to explain they may cause myocarditis in rare cases as a side effect. The agency said the side effect is very rare and patients generally recover quickly, but it can disportionally affect younger patients in their teens and early 20s. Getty Images

Getty Images

News | Coronavirus (COVID-19) | June 28, 2021 | Dave Fornell, Editor
June 28, 2021 — The U.S.
A small number of patients develop myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna. This recently raised concerns after numbers for this adverse reaction jumped in April and May, prompting review this week by the Centers for Disease Control and Prevention (CDC) Advisory Committee on the Immunization Practices (ACIP).

A small number of patients develop myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna. This recently raised concerns after numbers for this adverse reaction jumped in April and May, prompting review this week by the Centers for Disease Control and Prevention (CDC) Advisory Committee on the Immunization Practices (ACIP). Getty Images

Feature | Coronavirus (COVID-19) | June 24, 2021 | By Dave Fornell, Editor
A small number of patients develop inflammation leading to myocarditis after receiving the messenger RNA (mRNA)...